Serum level of soluble urokinase plasminogen activator receptor (suPAR) as a disease severity marker of myasthenia gravis: a pilot study.
Clin Exp Immunol
; 202(3): 321-324, 2020 12.
Article
in En
| MEDLINE
| ID: mdl-32706905
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Severity of Illness Index
/
Receptors, Urokinase Plasminogen Activator
/
Myasthenia Gravis
Type of study:
Prognostic_studies
Limits:
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Clin Exp Immunol
Year:
2020
Document type:
Article
Affiliation country:
Japón